We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$247M
Cap. Flow
-$496M
Cap. Flow %
-48.88%
Top 10 Hldgs %
63.97%
Holding
140
New
46
Increased
31
Reduced
3
Closed
42

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
3
OTIC
Otonomy, Inc.
OTIC
+$3.27M
4
INSM icon
Insmed
INSM
+$2.74M
5
FNSR
Finisar Corp
FNSR
+$2.04M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$14.9M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$1.64M
3
RAI
Reynolds American Inc
RAI
+$1.15M
4
AWH
Allied World Assurance Co Hld Lt
AWH
+$825K
5
MBLY
Mobileye N.V.
MBLY
+$691K

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.88%
2 Healthcare 3.4%
3 Communication Services 0.4%
4 Technology 0.31%
5 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
1
PUT
DELISTED
Zogenix, Inc.
ZGNX
$62.7M 6.18%
1,790,200
+1,588,700
+788% +$21.6M
NXH
2
CALL
Neighborhood Intelligence Inc
NXH
$375M
$40.7M 4.01%
+1,822,139
New +$27.5M
NXPI icon
3
CALL
NXP Semiconductors
NXPI
$56.4B
$39M 3.85%
345,300
+292,300
+552% +$32.6M
PTCT icon
4
PUT
PTC Therapeutics
PTCT
$5.85B
$34.7M 3.42%
+1,735,300
New +$34M
BMY icon
5
CALL
Bristol-Myers Squibb
BMY
$136B
$25.5M 2.51%
+400,000
New +$23.4M
NXH
6
PUT
Neighborhood Intelligence Inc
NXH
$375M
$20.6M 2.03%
+920,653
New +$13.9M
NXPI icon
7
PUT
NXP Semiconductors
NXPI
$56.4B
$18.7M 1.84%
165,600
+45,000
+37% +$5.02M
INTC icon
8
PUT
Intel
INTC
$473B
$15.2M 1.5%
400,000
+200,000
+100% +$7.11M
PTCT icon
9
PTC Therapeutics
PTCT
$5.85B
$12.3M 1.21%
+612,543
New +$12M
INSM icon
10
PUT
Insmed
INSM
$25.9B
$11.8M 1.16%
376,700
+81,700
+28% +$1.56M
SIOX
11
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$10.1M 1%
184,400
+83,450
+83% +$14.1M
IMMU
12
CALL
DELISTED
Immunomedics Inc
IMMU
$10.1M 0.99%
720,300
+259,100
+56% +$2.58M
ANIP icon
13
PUT
ANI Pharmaceuticals
ANIP
$1.67B
$9.58M 0.94%
182,500
+52,500
+40% +$2.5M
IMMU
14
PUT
DELISTED
Immunomedics Inc
IMMU
$8.69M 0.86%
621,800
+174,600
+39% +$1.74M
INSM icon
15
Insmed
INSM
$25.9B
$7.51M 0.74%
240,600
+143,870
+149% +$2.74M
INSM icon
16
CALL
Insmed
INSM
$25.9B
$6.64M 0.65%
+213,000
New +$4.06M
NBIX icon
17
Neurocrine Biosciences
NBIX
$15.7B
$6.36M 0.63%
+103,800
New +$5.48M
LCI
18
PUT
DELISTED
Lannett Company, Inc.
LCI
$6.27M 0.62%
+84,825
New +$6.23M
IVC
19
PUT
DELISTED
Invacare Corporation
IVC
$5.24M 0.52%
333,300
+233,300
+233% +$3.33M
DYNC
20
DELISTED
Vistra Energy Corp.
DYNC
$5.07M 0.5%
75,000
– –
ZGNX
21
CALL
DELISTED
Zogenix, Inc.
ZGNX
$4.7M 0.46%
134,000
+108,200
+419% +$1.47M
VGR
22
PUT
DELISTED
Vector Group Ltd.
VGR
$4.1M 0.4%
310,905
+82,390
+36% +$1.07M
DERM
23
PUT
DELISTED
Dermira, Inc.
DERM
$3.24M 0.32%
+120,100
New +$3.14M
KYNB
24
CALL
Kyntra Bio
KYNB
$32.5M
$3.06M 0.3%
+2,280
New +$2.4M
TEVA icon
25
PUT
Teva Pharmaceuticals
TEVA
$42.5B
$2.5M 0.25%
+142,300
New +$3.2M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, DLD Asset Management held 140 positions worth $1.02B, up 32% from $768M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

DLD Asset Management withdrew a net $496M in Q3 2017, closing 42 positions and reducing 3 holdings. Its most notable exit was Arista Networks, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DLD Asset Management opened a new position in PTC Therapeutics worth $12.3M.

  • DLD Asset Management's largest Q3 2017 buy was PTC Therapeutics: 612,543 shares worth $12.3M.
  • DLD Asset Management added most to Insmed in Q3 2017, an estimated $2.74M increase.
  • DLD Asset Management's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $138K.
  • DLD Asset Management fully exited Arista Networks in Q3 2017, selling an estimated $14.9M.
  • DLD Asset Management's ten largest holdings make up 64% of its $1.02B portfolio in Q3 2017.
  • DLD Asset Management opened 46 new positions and closed 42 in Q3 2017.
  • DLD Asset Management's portfolio value rose 32% quarter-over-quarter to $1.02B.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.